Icod 50 Injection contains Nandrolone Decanoate 50mg, an anabolic androgenic steroid used primarily for the treatment of anemia associated with chronic kidney disease, osteoporosis, and certain types of muscle wasting conditions. Nandrolone Decanoate promotes protein synthesis, nitrogen retention, and red blood cell production, thereby enhancing muscle growth, strength, and overall physical endurance. Administered via intramuscular injection, Icod 50 Injection provides a slow and sustained release of the active compound, ensuring prolonged therapeutic effects. It is indicated in patients requiring anabolic support to improve recovery and physical performance in catabolic states. Dosage and duration of treatment should be individualized based on patient response and clinical condition, with careful monitoring to minimize potential adverse effects such as virilization, fluid retention, and alterations in lipid profiles. Contraindications include known hypersensitivity to nandrolone or other components, prostate or breast carcinoma in males, and pregnancy or lactation in females. Caution is advised in patients with cardiovascular, hepatic, or renal impairment. Regular laboratory evaluations, including liver function tests and lipid panels, are recommended during therapy. Icod 50 Injection should be used under strict medical supervision to ensure safe and effective treatment outcomes.